Growth Metrics

Varex Imaging (VREX) EBIAT (2016 - 2026)

Varex Imaging (VREX) has disclosed EBIAT for 11 consecutive years, with $2.4 million as the latest value for Q1 2026.

  • On a quarterly basis, EBIAT rose 900.0% to $2.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$60.2 million, a 1380.85% decrease, with the full-year FY2025 number at -$69.9 million, down 48.09% from a year prior.
  • EBIAT was $2.4 million for Q1 2026 at Varex Imaging, down from $12.7 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $32.0 million in Q3 2023 to a low of -$90.1 million in Q3 2025.
  • A 5-year average of $1.5 million and a median of $4.8 million in 2022 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: tumbled 11362.5% in 2025, then skyrocketed 900.0% in 2026.
  • Varex Imaging's EBIAT stood at $5.4 million in 2022, then plummeted by 109.26% to -$500000.0 in 2023, then surged by 600.0% to $2.5 million in 2024, then surged by 408.0% to $12.7 million in 2025, then crashed by 81.1% to $2.4 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's EBIAT are $2.4 million (Q1 2026), $12.7 million (Q4 2025), and -$90.1 million (Q3 2025).